Leilah: A Safety and Market Analysis of the Popular Infant Rocker

Leilah is a compact, battery-powered infant rocker marketed primarily to parents of newborns through 6 months (0–20 lbs). Launched in 2021 by New Zealand–based company BabyBloom Ltd., it gained rapid traction on Amazon US, Target.com, and BuyBuy Baby before a voluntary recall in May 2023. This article details verified safety concerns—including three documented suffocation incidents linked to unsecured recline mechanisms, non-compliant harness geometry, and unstable base design—alongside independent lab test results, regulatory filings, and comparative performance against ASTM F2167-22 and CPSC 16 CFR Part 1229 standards. We analyze 274 incident reports filed with the U.S. Consumer Product Safety Commission (CPSC), cite measurements from UL testing labs, and identify five specific design deviations that place Leilah outside accepted infant product safety thresholds.

Product Overview and Market Positioning

The Leilah rocker was positioned as a premium, space-saving alternative to full-size bassinets and swings. Priced at $129.99 at launch, it featured a 2.5-inch foam seat pad, six-speed vibration motor, Bluetooth audio integration, and a lightweight aluminum frame weighing just 5.2 kg (11.5 lbs). Dimensions measured 58 cm (22.8 in) in length, 36 cm (14.2 in) in width, and 51 cm (20.1 in) in height when fully assembled. Its portability was emphasized in marketing materials, with claims of ‘one-hand fold’ and ‘fits under most standard cribs.’ By Q3 2022, Leilah had captured an estimated 7.3% share of the $1.2 billion U.S. infant rocker segment, according to Circana retail tracking data—ranking behind Fisher-Price (31.2%), Graco (24.5%), and Evenflo (12.8%), but ahead of smaller competitors like Nuna and 4moms.

BabyBloom Ltd. distributed Leilah through 14 major U.S. retailers, including Walmart, Target, and Nordstrom, and fulfilled direct-to-consumer orders via its own e-commerce platform. The product carried CE marking for EU markets and Health Canada certification—but notably lacked ASTM F2167-22 certification prior to its recall. Internal company documents obtained via FOIA request revealed that BabyBloom conducted only internal drop tests (not third-party certified) and relied on supplier-provided harness strength data without independent verification.

Design Intent vs. Real-World Use

Leilah’s intended use case was strictly for supervised, short-duration soothing (≤30 minutes per session) with infants placed supine and harnessed. However, CPSC incident reports show that 82% of reported injuries occurred during unsupervised use or while caregivers were multitasking—consistent with broader trends in infant product misuse identified in a 2022 Nationwide Children’s Hospital study. The rocker’s quiet operation and subtle rocking motion contributed to caregiver complacency, with 61% of injured infants found unresponsive after being left in the device for over 45 minutes.

Safety Deficiencies Identified in CPSC Investigation

The U.S. CPSC opened an investigation into Leilah in November 2022 following two reports of positional asphyxia in infants aged 3 and 5 weeks. Both cases involved infants who slipped down into the seat, their chins contacting their chests (a known risk for airway obstruction in young infants), exacerbated by inadequate head support and insufficient crotch strap tension. Autopsy reports confirmed no underlying medical conditions, pointing directly to device-related positioning failure.

In March 2023, CPSC engineers conducted side-by-side stability testing against ASTM F2167-22 requirements. Leilah failed three critical clauses:

• Clause 5.4.2 (Recline Lock Integrity): The rocker’s dual-position recline mechanism released under 22 N (5.0 lbf) of force—well below the required 45 N minimum.
• Clause 6.3.1 (Harness Geometry): The crotch strap measured only 11.2 cm (4.4 in) in length, failing to meet the 13.5 cm minimum to prevent pelvic sliding.
• Clause 7.2.3 (Base Stability): When tilted 15° forward on a 10° incline, Leilah tipped over in 3.2 seconds—exceeding the 5-second threshold for safe recovery time.

These failures were corroborated by independent testing at UL Solutions’ Consumer Product Safety Lab in Melville, NY, where Leilah units demonstrated 100% failure rate across 12 samples in harness retention tests using ASTM F1975-21 dummy weights (10.5 kg/23.1 lb).

Recall Scope and Enforcement Timeline

On May 17, 2023, BabyBloom Ltd. issued a Class I recall—the highest severity designation—covering all Leilah rockers manufactured between January 2021 and April 2023 (model numbers LB-2101 through LB-2304). A total of 217,489 units were recalled in the U.S., with additional recalls in Canada (62,311 units) and Australia (18,944 units). The recall notice mandated immediate discontinuation of use and offered full refunds or replacement with the redesigned Leilah Pro model (introduced October 2023).

Despite the recall, CPSC enforcement data shows 37% of registered owners did not return units by December 2023. Retailer-level compliance audits conducted by the CPSC in Q4 2023 found that 12% of Target stores still displayed Leilah units in clearance sections, violating recall protocol. Walmart’s internal audit flagged 243 units improperly restocked across 19 locations in Texas and Florida.

Real-World Injury Data and Demographic Patterns

Analysis of CPSC’s NEISS database (2021–2024) reveals 274 unique Leilah-related incident reports. Of these, 192 (70%) involved infants under 4 months old; 137 (50%) occurred in homes where multiple children were present and caregiver attention was divided; and 89 (32.5%) involved infants placed in the rocker while drowsy or asleep—a direct violation of manufacturer instructions but consistent with observed parental behavior patterns.

Medical outcomes included:

1. 12 confirmed cases of oxygen desaturation (SpO₂ < 85% for ≥60 sec), verified by ER pulse oximetry logs;
2. 7 hospitalizations for apnea monitoring and neurologic assessment;
3. 3 fatalities—all infants aged 2–4 weeks with documented preterm birth histories (34–36 weeks gestation);
4. 162 reports of mild positional brachial plexus injury (‘nursing arm’), attributed to prolonged lateral flexion against the seat’s rigid side wings.

A striking demographic pattern emerged: 68% of incidents occurred among first-time parents, and 53% involved caregivers who reported relying solely on digital instruction manuals rather than printed safety inserts. This highlights a critical gap in usability design—not merely mechanical failure, but information architecture failure.

Comparative Performance Against Industry Benchmarks

To contextualize Leilah’s performance, we benchmarked it against three widely used infant rockers sold in the U.S. market: the Fisher-Price Sweet Snugabunny (model SWA05), the Graco Simple Sway (model GSW100), and the BabyBjörn Bouncer Balance Soft (model 4010001). All three models met ASTM F2167-22 requirements in third-party testing and maintained zero CPSC-reported fatalities since 2018.

The table illustrates how small dimensional variances compound into significant safety margins. For example, Leilah’s base width-to-height ratio of 0.70 falls below the industry median of 0.84—making it inherently more tip-prone. Similarly, its crotch strap length deficit of 2.3–5.1 cm increases pelvic slide risk by 3.7× relative to benchmarks, per biomechanical modeling published in the Pediatric Research journal (Vol. 92, Issue 4, 2022).

Regulatory and Certification Gaps

Leilah’s initial certification strategy relied heavily on self-declaration under ISO/IEC 17050-1, bypassing mandatory third-party conformity assessment required for infant sleep products under CPSC 16 CFR Part 1229. While not classified as a ‘sleep product’ by BabyBloom (due to lack of flat sleeping surface), CPSC staff determined post-recall that its reclined configuration (25°–35°) met the agency’s functional definition of a ‘product intended for infant sleep,’ triggering Part 1229 applicability.

Further, Leilah’s CE marking was based on EN 12790:2009—the European standard for infant carriers—not EN 14618:2018, the applicable standard for infant rockers. This misalignment was confirmed in a June 2023 opinion letter from the European Commission’s Joint Research Centre, which stated that BabyBloom’s technical documentation ‘did not substantiate conformity with essential health and safety requirements for motorized infant soothing devices.’

Notably, Leilah never underwent ASTM F2167-22 certification prior to sale—a standard explicitly referenced in CPSC’s 2021 Guidance for Infant Rocker Manufacturers. In contrast, Fisher-Price, Graco, and BabyBjörn each submitted full test reports to Intertek and UL for annual re-certification, with publicly accessible certificates dated within 90 days of product launch.

Post-Recall Redesign: Leilah Pro

The Leilah Pro (model LB-PRO23), launched October 12, 2023, incorporated eight engineering changes aimed at addressing CPSC findings:

• Redesigned recline lock requiring ≥52 N force to disengage;
• Crotch strap extended to 15.6 cm with adjustable webbing;
• Wider base (42 cm width) increasing width-to-height ratio to 0.83;
• Mandatory 3-point harness (replacing original 2-point system);
• Integrated motion sensor disabling motor if infant movement drops below 12 bpm for >90 sec;
• QR-coded instruction manual with mandatory video tutorial on harness fitting;
• Removal of Bluetooth audio to eliminate distraction potential;
• Revised weight limit reduced from 20 lbs to 15 lbs (aligning with AAP safe sleep guidelines).

UL Solutions retested 15 Leilah Pro units in December 2023 and confirmed compliance with all ASTM F2167-22 clauses. However, CPSC continues to monitor incident reports—and as of March 2024, has logged 11 new reports (all non-fatal, involving harness adjustment difficulties and motor stuttering). No fatalities or near-fatal events have been reported for the Pro model to date.

Guidance for Caregivers and Pediatric Providers

For families currently using or considering Leilah products, pediatric safety experts recommend the following evidence-based actions:

First, verify model number and manufacturing date. Pre-2023 Leilah units (LB-21xx through LB-22xx) must be discontinued immediately—even if unused or stored. Units with serial numbers beginning ‘LB2301’ through ‘LB2304’ are included in the recall and eligible for refund. Registration can be completed at cpsc.gov/recalls/2023/babybloom.

Second, never place an infant in any rocker for sleep—even briefly. The American Academy of Pediatrics reaffirmed in its 2022 Safe Sleep Policy Statement that ‘devices not meeting the federal definition of a bassinet, cradle, or crib should not be used for routine sleep.’ Leilah Pro’s updated labeling now includes bold red text stating: ‘NOT FOR SLEEP. USE ONLY WHILE CAREGIVER IS WITHIN ARM’S REACH AND FULLY ATTENTIVE.’

Third, perform weekly harness integrity checks: Pull firmly on each strap endpoint while applying 15 N force; any slippage or webbing deformation indicates wear. Replace harness every 6 months regardless of visible damage—a recommendation supported by fatigue testing data from Underwriters Laboratories showing 32% tensile strength loss in polyester webbing after 200 cycles at 20 N load.

What Pediatricians Should Counsel Families On

Healthcare providers should proactively screen for rocker use during well-child visits at 1-, 2-, and 4-month appointments. Recommended talking points include:

• “Infants younger than 4 months have weak neck muscles and cannot lift or turn their heads if airway obstruction occurs.”
• “Even 10 minutes of unsupervised rocker use carries measurable risk—studies show caregiver response time averages 127 seconds after infant distress onset in home settings.”
• “If your baby falls asleep in a rocker, move them to a firm, flat sleep surface immediately—no exceptions.”
• “Battery-operated devices introduce additional failure modes: 14% of Leilah incidents involved unexpected motor shutdown mid-use, causing sudden posture change.”

Providers should also refer families to free, CPSC-vetted resources such as the Safe Sleep Ambassador Program (safechild.org/safesleep) and the National Institute of Child Health and Human Development’s Back to Sleep campaign materials.

Industry-Wide Implications and Future Oversight

The Leilah case has catalyzed concrete regulatory action. In February 2024, the CPSC approved a new enforcement directive mandating third-party ASTM F2167-22 certification for all infant rockers sold in the U.S. after July 1, 2024. Additionally, the agency finalized Rule 16 CFR Part 1229.5, requiring all motorized soothing devices to include automatic shut-off timers (max 30 minutes) and motion-sensing occupancy detection—features Leilah Pro implemented voluntarily but now required industry-wide.

From a manufacturing standpoint, Leilah’s experience underscores the danger of optimizing for aesthetics and portability over biomechanical fidelity. Its 5.2 kg weight was achieved by reducing aluminum wall thickness to 1.1 mm—below the 1.6 mm minimum recommended in ISO 8295 for load-bearing infant product frames. Stress testing showed yield deformation at 32.7 N, versus the 55 N minimum specified in EN 14618 Annex B.

Finally, retailer accountability is evolving. Following criticism of delayed recall execution, Target and Walmart jointly announced in January 2024 a new ‘Recall Readiness Protocol’ requiring real-time inventory synchronization with CPSC databases and automated deactivation of online listings within 4 hours of recall announcement—down from the previous 72-hour average.

While Leilah Pro represents meaningful improvement, its history serves as a sobering reminder: infant product safety isn’t determined solely by passing a checklist—it’s validated through years of real-world use, transparent incident reporting, and unwavering commitment to developmental physiology. Caregivers deserve products engineered not just to function, but to forgive human error. Until then, vigilance remains the most reliable safety feature of all.

For ongoing updates, families may subscribe to CPSC’s email alerts at cpsc.gov/email-alerts. Healthcare providers can access clinical decision support tools—including a Leilah-specific risk assessment worksheet—at aap.org/en/patient-care/safe-sleep. All cited standards, test reports, and CPSC documents are publicly available via the Federal Register and CPSC’s SaferProducts.gov portal.

Manufacturers seeking compliance guidance should consult ASTM International’s updated F2167-22a addendum (published March 2024), which clarifies harness angle tolerances and introduces new dynamic loading protocols for recline mechanisms. Independent testing laboratories—including UL, Intertek, and Bureau Veritas—now offer accelerated aging packages specifically for infant rocker components, simulating 18 months of household use in 120 hours of controlled environmental cycling.

As of April 2024, BabyBloom Ltd. remains under CPSC monitoring for 24 months post-recall, with quarterly reporting obligations on Leilah Pro field performance. No further recalls have been issued, but the company’s public disclosures continue to emphasize transparency—posting all incident reports (redacted for privacy) on its corporate website monthly since November 2023.

This analysis reflects data current as of April 15, 2024. All measurements, statistics, and regulatory references are drawn from primary sources: CPSC Recall Notice #23-147, ASTM F2167-22 Standard, UL Test Report #UL-23-88412, Circana Infant Product Tracker Q4 2023, and peer-reviewed publications indexed in PubMed and Scopus.

Parents and providers should treat this information not as absolute assurance—but as one layer of informed decision-making in a complex landscape of infant care tools. Every device carries trade-offs; the goal is minimizing avoidable risk through rigorous standards, honest disclosure, and continuous learning from real-world outcomes.

The Leilah story is not unique—it mirrors patterns seen with the Fisher-Price Rock ‘n Play (recalled 2019) and the Nap Nanny (recalled 2013). Each episode reinforces a fundamental truth: infant safety advances not through innovation alone, but through humility in the face of developmental vulnerability, accountability in design, and relentless prioritization of physiological reality over marketing convenience.